Press "Enter" to skip to content

FDA Postpones Plan To Decrease Nicotine Levels In Customary Cigarettes

Recently, the FDA (Food and Drug Administration) issued a list of guidelines it intends to work on in the next year, omitted from that list was a directive to decrease nicotine levels in customary cigarettes. That directive was primarily declared by Scott Gottlieb—Ex-FDA Commissioner—in 2017. The AHA (American Heart Association) circulated the statement saying, “We are extremely disappointed the government seems to have abandoned or delayed a directive to decrease the quantity of nicotine in traditional cigarettes to simply addictive or nonaddictive levels. The decreasing nicotine levels in flammable tobacco products will noticeably decrease their appeal, leading tobacco use to fall, reducing tobacco-associated illness and death consequences.

It will have a huge impact on the millions of cigarette smokers, who are at present addicted to products that are very dangerous. The FDA’s recoil on nicotine in customary cigarettes came just a few days following reports the government will fall far short of its earlier stated aim to eliminate flavored electronic cigarettes from the market. This is good news for the tobacco industry and bad news for the millions of people countrywide who are affected by tobacco use.

On a similar note, recently, a study showed that e-cigarettes cause damage to the heart’s health. The use of e-cigarette is a big concern considering the high occurrence of e-cigarettes and insight of e-cigarettes as a healthier option for traditional cigarettes, as per new research that was submitted at the AHA’s Scientific Sessions 2019. Researchers who carried two separate studies stated that they discovered e-cigarette smokers had additional negative heart disease peril factors and these cigarettes lower the blood flow in the heart. Rose Marie Robertson—Deputy Chief Science and Medical Officer of AHA—said, “There is no long-duration safety information on e-cigarettes. Nonetheless, there are decades of facts for the security of other nicotine substitution therapies.”

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *